Skip to main content
. 2020 Nov 25;75:e2273. doi: 10.6061/clinics/2020/e2273

Table 2. Risk of negative outcomes according to viral agent in pediatric patients with severe acute respiratory illness.

Crude model Adjusted model*
Outcomes OR 95% CI p OR 95% CI p
PICU
    Influenza 1.00 1.00
    ORV 1.23 1.00-1.50 0.04 1.15 0.94-1.42 0.16
    SARS-CoV-2 1.00 0.82-1.21 0.98 1.03 0.85-1.25 0.76
Invasive VS
    Influenza 1.00 1.00
    ORV 1.94 1.43-2.65 <0.001 1.81 1.33-2.47 <0.001
    SARS-CoV-2 1.10 0.80-1.42 0.66 1.11 0.83-1.49 0.47
Noninvasive VS
    Influenza 1.00 1.00
    ORV 2.63 2.12-3.25 <0.001 2.41 1.95-3.00 <0.001
    SARS-CoV-2 0.81 0.66-0.99 0.04 0.85 0.69-1.04 0.116
Death
    Influenza 1.00 1.00
    ORV 0.71 0.44-1.15 0.163 0.72 0.45-1.17 0.186
    SARS-CoV-2 3.78 2.53-5.66 <0.001 3.74 2.50-5.60 <0.001

Data represent closed cases entered into the National Epidemiological Surveillance Information System between January 1st and July 14th, 2020.

*

Adjusted for sex and age.

PICU=pediatric intensive care unit; ORV=other respiratory virus (respiratory syncytial virus, adenovirus, parainfluenza 1, parainfluenza 2, parainfluenza 3, parainfluenza 4, metapneumovirus, bocavirus, rhinovirus); OR=odds ratio; 95% CI=95% confidence interval; VS=ventilatory support.